Separating and/or identifying polymorphic nucleic acids using universal bases

• US 20040014101A1
• Filed: 05/05/2003
• Published: 01/22/2004
• Est. Priority Date: 05/03/2002
• Status: Abandoned Application

• Current Assignee: Invitrogen Dynal AS (Invitrogen Dynal Holding AS)
• Original Assignee: Pel-Freez Clinical Systems, Inc.
• Inventors: Wang, Lu, Liu, Xiangjun, Ramon, Daniel S.
• Application Number:
  US10/429,912
• Publication Number:
  US 20040014101A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6858 Allele-specific amplification
• CPC Class Codes: C12Q 1/6881 for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
• CPC Class Codes: C12Q 2525/101 incorporating non-naturally occurring nucleotides, e.g. inosine
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers
• CPC Class Codes: C12Q 2600/16 Primer sets for multiplex assays

Abstract

The present invention provides methods for analyzing polymorphic nucleic acids using duplex separation and/or identification techniques. In the present methods one of the nucleic acids has a sequence which includes universal bases that correspond in position to one or more of the polymorphic positions of the polymorphic nucleic acid. The nucleic acid including the universal bases can either represent the polymorphic nucleic acid and hybridize with a reference strand, or act as a reference strand and hybridize with the polymorphic nucleic acid directly, to form a duplex. Separation and/or identification of the duplex from other duplexes and materials can then be performed.

Claims

1. A method for identifying a nucleic acid molecule, comprising:

(a) hybridizing a first nucleic acid whose sequence matches, or is complementary to, a nucleic acid having a plurality of polymorphic positions with a reference nucleic acid whose sequence is substantially complementary to the first nucleic acid to form a test duplex, wherein one or more of the polymorphic positions, or the positions complementary thereto, of the first nucleic acid are replaced with a universal base; and

(b) separating the test duplex.

2. The method of claim 1, further comprising:

(c) detecting the presence or absence of the test duplex;

(d) identifying the first nucleic acid;

or

(e) both (c) and (d).

3. The method of claim 1 wherein the first nucleic acid is produced by:

(i) hybridizing a polymorphic nucleic acid having one or more polymorphic positions or a nucleic acid complementary thereto with a complementary nucleic acid primer that has at least one universal base complementary to at least one polymorphic position of the polymorphic nucleic acid; and

(ii) elongating the nucleic acid primer.

4. The method of claim 1 wherein the first nucleic acid is an HLA allele.

5. The method of claim 4 wherein the HLA allele is HLA-DRB1.

6. The method of claim 5 wherein all of the different first nucleic acids have at least one universal base in a polymorphic position, or position complementary thereto, which is common to all of the HLA-DRB1 alleles.

7. The method of claim 1 wherein the universal base is 2′

-deoxyinosine, 3-nitropyrrole (3-nitropyrrole 2′

-deoxynucleoside), 5-nitroindole (5-nitroindole 2′

-deoxynucleoside), 4-nitroindole (4-nitroindole 2′

-deoxynucleoside), 6-nitroindole (6-nitroindole 2′

-deoxynucleoside), 2′

-deoxynebularine, N6-methoxy-2,6-diaminopurine, or 6H,8H-3,4-dihydropyrimido[4,5-c][1,2]oxazin-7-one.

8. The method of claim 1 wherein the first nucleic acid, reference nucleic acid or both are labeled.

19. The modified nucleic acid of claim 20 wherein the universal base is 2′

-deoxyinosine, 3-nitropyrrole (3-nitropyrrole 2′

-deoxynucleoside), 5-nitroindole (5-nitroindole 2′

-deoxynucleoside), 4-nitroindole (4-nitroindole 2′

-deoxynucleoside), 6-nitroindole (6-nitroindole 2′

-deoxynucleoside), 2′

-deoxynebularine, N6-methoxy-2,6-diaminopurine, or 6H,8H-3,4-dihydropyrimido[4,5-c][1,2]oxazin-7-one.

20. A kit for identifying a nucleic acid molecule comprising:

(i) instructions for carrying out the method of claim 1 and one or more;

(ii) reagents, (iii) primers, (iv) solid supports (v) enzymes or (vi) pieces of lab equipment.

9. A method for identifying a nucleic acid molecule, comprising:

(a) hybridizing a polymorphic nucleic acid having one or more polymorphic positions with a reference nucleic acid that is substantially complementary to a reference nucleic acid to form a test duplex, wherein one or more positions of the reference nucleic acid complementary to the one or more polymorphic position are replaced with a universal base; and

(b) separating the test duplex.

10. The method of claim 9 further comprising:

(c) detecting the presence or absence of the test duplex;

(d) identifying the polymorphic nucleic acid;

or

(e) both (c) and (d).

11. The method of claim 9 wherein the polymorphic nucleic acid does not form a stable duplex with the reference nucleic acid in the absence of the nucleic acid having universal bases.

12. The method of claim 9 wherein the reference nucleic acid has a sufficient amount of the positions complementary to the one or more polymorphic positions of the polymorphic nucleic acid replaced with universal bases in order to stabilize the test duplex relative to a test duplex with a control nucleic acid having the same sequence that does not have universal nucleic acids and further wherein a sufficient amount of the polymorphic positions, or positions complementary thereto, are not replaced with universal bases such that all alleles which have different polymorphic sequences within the primer annealing region can be identified utilizing the same reference nucleic acid.

13. The method of claim 9 wherein the polymorphic nucleic acid is an HLA allele.

14. The method of claim 13 wherein the reference nucleic acid is capable of specifically identifying all of the HLA alleles of an HLA gene subfamily but not the HLA alleles of related HLA gene subfamilies.

15. The method of claim 14 wherein the HLA gene subfamily is HLA-DRB1.

16. The method of claim 15 wherein the reference nucleic acid comprises the sequence set forth in SEQ ID NO:

1 (TTGNNGCAGGTTAANNNTGAG), SEQ ID NO;

2 (GNCCCCNCAGCACGTTTCCTGNN GCAGGTTAANNNTGAGTGTCATTTC), SEQ ID NO;

3 (GNCCCCNCAGCACGTTTCNTGNNGNANNNTANNNNNNANTGTNANTTCTTCAAT), SEQ ID NO;

4 (GNCCCCNCAGCACGTTTCNTGNNGNANNNTANNNNTNAGTGTNATTTCTTCAAT) or a nucleic acid having a sequence complementary to SEQ ID NO;

1, SEQ ID NO;

2, SEQ ID NO;

3 or SEQ ID NO;

4.

17. The method of claim 9 wherein the polymorphic nucleic acid, reference nucleic acid or both are labeled.

21. A kit for identifying a nucleic acid molecule comprising:

(i) instructions for carrying out the method of claim 9 and one or more;

(ii) reagents, (iii) primers, (iv) solid supports (v) enzymes or (vi) pieces of lab equipment.

18. A modified nucleic acid comprising the sequence set forth in SEQ ID NO:

1 (TTGNNGCAGGTTAANNNTGAG), SEQ ID NO;

2 (GNCCCCNCAGCACGTTTCCTGNN GCAGGTTAANNNTGAGTGTCATTTC), SEQ ID NO;

3 (GNCCCCNCAGCACGTTTCN TGNNGNANNNTANNNNNNANTGTNANTTCTTCAAT), SEQ ID NO;

4 (GNCCC CNCAGCACGTTTCNTGNNGNANNNTANNNNTNAGTGTNATTTCTTCAAT) or a nucleic acid having a sequence complementary to SEQ ID NO;

1, SEQ ID NO;

2, SEQ ID NO;

3 or SEQ ID NO;

4, wherein N denotes a universal base that is capable of hybridizing to any other nucleic acid residue.